Insider Transactions in Q2 2022 at Pear Therapeutics, Inc. (PEAR)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 25
2022
|
Erin K. Brenner Chief Product Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$15,000
$1.0 P/Share
|